NCT02306577View on ClinicalTrials.gov

STRIBILD in Non-Nucleoside Resistant Patients (SINNR STUDY)

UnknownOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

July 31, 2016

Conditions
HIVIllicit Drug User
Interventions
DRUG

STRIBILD

Taking oral 1 STRIBILD tablet once a day for 48 weeks

Trial Locations (1)

V6Z 2C7

RECRUITING

Vancouver ID Research and Care Centre Society, Vancouver

Sponsors

Collaborators (1)

Gilead Sciences
All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

collaborator

Regina General Hospital

OTHER

lead

Vancouver Infectious Diseases Centre

OTHER